| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
|
Blood
|
2007
|
5.18
|
|
2
|
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
|
J Clin Oncol
|
2005
|
3.61
|
|
3
|
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1.
|
Nat Genet
|
2002
|
2.87
|
|
4
|
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
|
Blood
|
2011
|
2.37
|
|
5
|
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.
|
Blood
|
2007
|
2.36
|
|
6
|
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
|
J Clin Oncol
|
2009
|
2.00
|
|
7
|
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
|
Blood
|
2003
|
1.99
|
|
8
|
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
|
Blood
|
2006
|
1.89
|
|
9
|
Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome.
|
Nephrol Dial Transplant
|
2006
|
1.76
|
|
10
|
Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.
|
J Clin Oncol
|
2012
|
1.66
|
|
11
|
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
|
Cancer
|
2007
|
1.61
|
|
12
|
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.
|
Blood
|
2011
|
1.26
|
|
13
|
Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development.
|
EMBO Rep
|
2006
|
1.21
|
|
14
|
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
|
PLoS One
|
2013
|
1.17
|
|
15
|
Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
|
Eur J Pharmacol
|
2005
|
1.16
|
|
16
|
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
|
Blood
|
2004
|
1.10
|
|
17
|
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.
|
Blood
|
2009
|
1.08
|
|
18
|
Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease.
|
Stem Cells
|
2011
|
1.07
|
|
19
|
Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
|
Genes Chromosomes Cancer
|
2014
|
1.06
|
|
20
|
The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia.
|
Br J Haematol
|
2008
|
1.03
|
|
21
|
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia.
|
Blood
|
2002
|
1.00
|
|
22
|
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
|
Cancer Res
|
2007
|
1.00
|
|
23
|
Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.
|
Int J Hematol
|
2009
|
0.99
|
|
24
|
Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
|
Eur J Haematol
|
2004
|
0.98
|
|
25
|
Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena.
|
Int J Hematol
|
2011
|
0.98
|
|
26
|
Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
|
Ann Hematol
|
2008
|
0.98
|
|
27
|
Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs.
|
Onkologie
|
2010
|
0.98
|
|
28
|
The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.
|
Clin Cancer Res
|
2006
|
0.98
|
|
29
|
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.
|
Blood
|
2010
|
0.96
|
|
30
|
Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
|
Ann Hematol
|
2011
|
0.95
|
|
31
|
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
|
Clin Cancer Res
|
2006
|
0.95
|
|
32
|
The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice.
|
Blood
|
2012
|
0.95
|
|
33
|
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.
|
Blood
|
2005
|
0.94
|
|
34
|
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2006
|
0.93
|
|
35
|
Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure--Feasibility, safety and effects on exercise tolerance and cardiac function.
|
Basic Res Cardiol
|
2005
|
0.93
|
|
36
|
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia.
|
J Clin Oncol
|
2010
|
0.93
|
|
37
|
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia.
|
Br J Haematol
|
2007
|
0.92
|
|
38
|
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
|
J Clin Oncol
|
2013
|
0.92
|
|
39
|
Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.
|
Cancer Cell
|
2013
|
0.91
|
|
40
|
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
|
Cancer Genet Cytogenet
|
2009
|
0.90
|
|
41
|
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma.
|
Support Care Cancer
|
2011
|
0.89
|
|
42
|
Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
|
Eur J Haematol
|
2009
|
0.89
|
|
43
|
Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
|
Cancer Immunol Immunother
|
2013
|
0.88
|
|
44
|
Telomeres and prognosis in patients with chronic lymphocytic leukaemia.
|
Int J Hematol
|
2011
|
0.88
|
|
45
|
Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.
|
PLoS One
|
2012
|
0.88
|
|
46
|
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
|
Pharmacogenet Genomics
|
2006
|
0.88
|
|
47
|
Two cases of pancreatic tuberculosis in nonimmunocompromised patients. A diagnostic challenge and a rare cause of portal hypertension.
|
Pancreatology
|
2002
|
0.87
|
|
48
|
Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study.
|
Ann Hematol
|
2013
|
0.85
|
|
49
|
Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study.
|
PLoS One
|
2012
|
0.85
|
|
50
|
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2009
|
0.85
|
|
51
|
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
|
Blood
|
2012
|
0.83
|
|
52
|
NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis.
|
Blood
|
2007
|
0.83
|
|
53
|
Gene dosage effects in chronic lymphocytic leukemia.
|
Cancer Genet Cytogenet
|
2010
|
0.83
|
|
54
|
Gene expression profiles in murine hematopoietic stem cells revisited: analysis of cDNA libraries reveals high levels of translational and metabolic activities.
|
Stem Cells
|
2006
|
0.83
|
|
55
|
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
|
Eur J Haematol
|
2011
|
0.82
|
|
56
|
HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
|
Semin Cancer Biol
|
2007
|
0.82
|
|
57
|
High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.
|
Clin Immunol
|
2009
|
0.81
|
|
58
|
Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48.
|
Am J Blood Res
|
2012
|
0.80
|
|
59
|
Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
|
Leuk Res
|
2008
|
0.80
|
|
60
|
Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma.
|
J Clin Oncol
|
2010
|
0.80
|
|
61
|
Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia.
|
Ann Hematol
|
2009
|
0.80
|
|
62
|
1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
|
Eur J Haematol
|
2004
|
0.80
|
|
63
|
B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.
|
Leuk Lymphoma
|
2004
|
0.79
|
|
64
|
The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels.
|
Eur J Haematol
|
2010
|
0.79
|
|
65
|
Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.
|
Eur J Haematol
|
2011
|
0.79
|
|
66
|
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.
|
PLoS One
|
2013
|
0.78
|
|
67
|
p53 protein expression in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2012
|
0.78
|
|
68
|
Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.
|
Br J Haematol
|
2008
|
0.78
|
|
69
|
Prognostic significance of molecular remission in follicular lymphoma.
|
J Clin Oncol
|
2010
|
0.78
|
|
70
|
Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.
|
Ann Hematol
|
2005
|
0.78
|
|
71
|
Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
|
Clin Lab Haematol
|
2006
|
0.77
|
|
72
|
FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
|
Eur J Haematol
|
2009
|
0.77
|
|
73
|
The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia.
|
Leuk Lymphoma
|
2003
|
0.77
|
|
74
|
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
|
Ann Hematol
|
2007
|
0.76
|
|
75
|
Hand-foot syndrome: common presentation in an uncommon situation.
|
Eur J Haematol
|
2013
|
0.76
|
|
76
|
Prognostic significance of serum cystatin C in multiple myeloma.
|
Int J Hematol
|
2012
|
0.76
|
|
77
|
Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: effects on the hematopoietic system.
|
Transfusion
|
2006
|
0.76
|
|
78
|
Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia.
|
Int J Hematol
|
2015
|
0.75
|
|
79
|
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report.
|
Biol Blood Marrow Transplant
|
2013
|
0.75
|
|
80
|
Cold agglutinin disease.
|
Eur J Haematol
|
2009
|
0.75
|
|
81
|
Nodular lesions of the scalp and a mediastinal mass in T cell acute lymphoblastic leukemia.
|
Int J Hematol
|
2010
|
0.75
|
|
82
|
Acral ischemia as a presenting manifestation of essential thrombocythemia.
|
Int J Hematol
|
2011
|
0.75
|
|
83
|
The Maze of Diagnosing Hemophagocytic Lymphohistiocytosis: Single-Center Experience of a Series of 6 Clinical Cases.
|
Oncology
|
2017
|
0.75
|
|
84
|
Porphyria cutanea tarda.
|
Br J Haematol
|
2009
|
0.75
|
|
85
|
Amyloid tumour.
|
Br J Haematol
|
2009
|
0.75
|
|
86
|
[56-year-old female patient with jaundice and paraparesis].
|
Dtsch Med Wochenschr
|
2010
|
0.75
|
|
87
|
A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
|
Acta Haematol
|
2016
|
0.75
|
|
88
|
Paroxysmal nocturnal hemoglobinuria turning Coombs-positive.
|
Int J Hematol
|
2010
|
0.75
|